nShift Insurance Helps Retailers Cut the Cost of Lost, Damaged or Stolen Deliveries
8.10.2024 10:34:00 CEST | Business Wire | Press release
With “porch piracy” on the rise, nShift now offers protection for ecommerce retailers
Retailers are staring at an ever-increasing black hole in their bottom line when it comes to covering the cost of lost, damaged, or stolen deliveries. Over half of consumers say they receive damaged goods each year1, which soon adds up for retailers. The typical insured loss for damaged packages is €218, and insured missing packages typically cost €2952.
That’s why nShift, the global leader in delivery & experience management (DMXM), provides online retailers, brands and webshops with a simple insurance offer.
Retailers can be swiftly refunded for items that are lost, stolen, or damaged in delivery. nShift Insurance is an alternative to the policies offered by carriers, whose terms can vary considerably, and often involve long settlement times. This enables them to provide better service to their customers, build loyalty, and reduce operating risks.
More and more ecommerce purchases are either stolen or damaged before they reach customers. “Porch piracy” - the theft of parcels left in doorways and other “safe places” - increased 57% in 2023 with estimated losses of €236m (£200m) in the UK alone.3 According to data from Cover Genius, the cost of replacing an item is 4% higher compared with the original cost of shipping it.
Maarten Tops, Product Director at nShift said, “The time and cost of replacing lost, damaged, or stolen deliveries is set to worsen as the ecommerce market grows. While many carriers offer insurance of their own, the terms and conditions vary considerably, and it can take a long time for payouts to be handled. nShift Insurance is based on industry-leading underwriters and offers coverage that is tailored to the needs of ecommerce companies – across all the carriers they use.”
Benefits of nShift Insurance
nShift offers insurance across its delivery management portfolio, including nShift Ship, Delivery, and Transsmart. Benefits to retailers include:
- Simplified process - carrier-agnostic, global protection covering all available carriers
- Greater customer loyalty - through a seamless claims process that offers faster payouts and speedier replacements
- Tailored protection options - so retailers are adequately protected for the products they sell
- Convenience - fully embedded into a merchant’s working processes (such as booking and label printing)
- No minimum wait times to submit claims - investigations are started without having to wait for carriers marking parcels as lost or damaged
- Rapid payouts for approved claims - nShift Insurance aims to complete 95% of claims within three days of claim filing
- Reimbursements relative to loss - equal to the full retail value of lost, stolen, or damaged goods
- Tailored protection options - that can be attached in-path or at an account level
Maarten Tops continued, “Online retailers and carrier companies typically take great care to ensure that customers receive their items in great condition. But accidents happen. For ecommerce and retailers, nShift Insurance gives more control, and better peace of mind.”
Part of nShift’s delivery & experience management (DMXM) suite of solutions that link brands with customers, nShift Insurance is available for Delivery, Ship, or Transsmart customers. Find out more about nShift Insurance.
About nShift
nShift’s delivery & experience management (DMXM) platform drives ecommerce success. Grow beyond limits with constant innovation and the world’s largest carrier network. Build customer loyalty with end-to-end tools that enhance experience. Unify data into usable insight that connects and optimizes processes. With nShift, make delivery the essential link between your brand and your customers.
nShift. Worry less. Ship smarter. www.nshift.com
Time savings are based on average resolution times (i.e. the duration from initial filing to completed payment) for all XCover shipping protection claims as at May 31, 2022 (sample size = 868) compared with the industry average time including payment settlement (min. 6 days) and period to acknowledge a filed claim.
1https://www.amcor.com/insights/blogs/how-much-a-damaged-pack-can-really-cost-your-business
2 Based on claims data from nShift partner, Cover Genius
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008855559/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom